文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > Therapeutic targeting of the PDGF and TGF-b-signaling
侵权投诉

Therapeutic targeting of the PDGF and TGF-b-signaling

hsc

LaboratoryInvestigation(2009)89,1152–1160&2009USCAP,IncAllrightsreserved0023-6837/09$32.00

TherapeutictargetingofthePDGFandTGF-b-signalingpathwaysinhepaticstellatecellsbyPTK787/ZK22258

YuqingLiu1,2,3,XiaoMingWen1,EricLikHangLui3,ScottLFriedman4,WeiCui2,NancyPeiShanHo2,LeiLi3,TaoYe1,2,SheungTatFan3andHuiZhang1,5

Stimulationofhepaticstellatecells(HSCs)byplatelet-derivedgrowthfactor(PDGF)andtransforminggrowthfactor-b1(TGF-b1)isanessentialpathwayofproliferationandfibrogenesis,respectively,inliverfibrosis.WeprovideevidencethatPTK787/ZK222584(PTK/ZK),apotenttyrosinekinaseinhibitorthatblocksvascularendothelialgrowthfactorreceptor(VEGFR),significantlyinhibitsPDGFreceptorexpression,aswellasPDGF-simulatedHSCproliferation,migrationandphosphorylationofERK1/2,Aktandp70S6kinase.Interestingly,PTK/ZKalsoantagonizestheTGF-b1-inducedexpressionofVEGFandVEGFR1.Furthermore,PTK/ZKdownregulatesTGF-breceptorexpression,whichisassociatedwithreducedAkt,ERKandp38MAPKphosphorylation.Furthermore,PDGF-inducedTGF-b1expressionisinhibitedbyPTK/ZK.ThesefindingsprovideevidencethatPTK/ZKtargetsmultipleessentialpathwaysofstellatecellactivationthatprovokeproliferationandfibrogenesis.OurstudyunderscoresthepotentialuseofPTK/ZKasanantifibroticdruginchronicliverdisease.

LaboratoryInvestigation(2009)89,1152–1160;doi:10.1038/labinvest.2009.77;publishedonline10August2009

KEYWORDS:Akt;HSC;PDGF;PTK787/ZK22258;TGF-b1

Liverfibrosisisapathologicalresponseofthelivertoavarietyofchronicstimuli.Hepaticstellatecells(HSCs)playanessentialroleinthedevelopmentofliverfibrosis.Afterchronicliverinjury,HSCsundergoaprocessofactivation,developingamyofibroblast-likephenotypethatproliferatesandbecomesfibrogenic1,2andproducesincreasedextra-cellularmatrixproteins.3

Severalcytokinemediatesarecentraltothefibroticpro-cess,includingplatelet-derivedgrowthfactor(PDGF)andtransforminggrowthfactor-b1(TGF-b1).PDGFisthemostpotentproliferativecytokinetowardHSCs,whereasTGF-b1primarilyfunctionsinthestimulationofextracellularmatrixproduction.3Intheliver,expressionofPDGFanditsre-ceptorsisincreasedbothinexperimentalfibrosisinratsandinhumanfibroticliver.4–6BothPDGF-BandPDGFR-barerapidlyinducedinvivoandinculture.4,7Moreover,thege-neticoverexpressionofPDGFleadstoliverfibrosisinmice.8Remarkably,veryfewstudieshaveassessedtheimpactof

1

PDGFantagonismonhepaticfibrosis.9Recentreportsusingimatinibmesylate(Gleevec)showpromise,10–12butitisuncertainwhetherPDGFRisitsmaintargetofactioninthesestudies.

TGF-b1isthemostpotentstimulustohepaticfibrogen-esis.13IncreasedlevelsofTGF-bhavebeendescribedinchronicliverdiseases,andactivatedHSCsrepresentamajorcellularsourceofTGF-bininjuredliver.InHSCs,TGF-bpromotesHSCtransformationintomyofibroblasts,simulatesthesynthesisofextracellularmatrixproteinsandinhibitstheirdegradation.AntagonismofTGF-b1signalingpathwaysmarkedlydecreasesfibrosisinexperimentalmodels.14,15

Becauseoftheircombinedrolesinfibrosis,inhibitingPDGFandTGF-b1signaltransductionisanattractivetargetforantifibrotictherapy.Anemergingstrategyistogeneratesmall-moleculeinhibitorsofreceptortyrosinekinasedo-mains.PTK787/ZK22258(PTK/ZK)isapotenttyrosinekinaseinhibitorofbothvascularendothelialgrowthfactor

LaboratoryofChemicalGenomics,SchoolofChemicalBiologyandBiotechnology,ShenzhenGraduateSchoolofPekingUniversity,Shenzhen,China;2DepartmentofAppliedBiology&ChemicalTechnology,TheHongKongPolytechnicUniversity,Kowloon,HongKong,China;3DepartmentofSurgery,TheUniversityofHongKong,Pokfulam,HongKong,China;4DivisionofLiverDiseases,MountSinaiSchoolofMedicine,NewYork,NY,USAand5CancerCellProteomics,NevadaCancerInstitute,LasVegas,NV,USA

Correspondence:DrYLiu,MD,PhDorProfessorHuiZhang,LaboratoryofChemicalGenomics,SchoolofChemicalBiologyandBiotechnology,ShenzhenGraduateSchoolofPekingUniversity,Shenzhen518055,ChinaorDrYLiu,MD,PhD,DepartmentofAppliedBiology&ChemicalTechnology,TheHongKongPolytechnicUniversity,Kowloon,HongKong,China.

E-mails:yuqing_liu@hotmail.comorzhanghui2006@szpku.edu.hk

Received3October2008;revised27May2009;accepted13June2009

1152

LaboratoryInvestigation|Volume89October2009|doc.guandang.net

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email